Answers are grounded in this paper and cite their sources.
Lymphofluoroscopy can identify an early disturbance of lymphatic transport after breast cancer treatment. Patients with an early disturbance of lymphatic transport are considered to be a high-risk group for the development of BCRL. This study also confirms that age and ALND are predictors for the development of BCRL. Therefore, a surveillance program of these patients with lymphofluoroscopy could be useful to identify lymphedema in subclinical stages.
No takes yet. Share an insight, caveat, or question.
Thomis et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: